You are here
Home > News >

7 pharma companies slash remdesivir price | India News – Times of India


NEW DELHI: In a relief to Covid-19 patients, pharmaceutical companies manufacturing Remdesivir In India has significantly lowered prices of the drug being given to patients with severe infection in hospitals following government’s intervention last week.
The price of Remdesivir has dropped to the range of Rs 899-3,490 per 100ml vial from Rs 2,800-5,400 earlier depending on brands. The seven manufacturers have voluntarily reduced the prices in view of the Covid-19 pandemic.
The development assumes significance as Covid-19 cases are rising significantly across the country with large numbers of severe cases in hospitals needing oxygen and ventilator support.
Following concerns about shortage and high price of Remdesivir in the wake of a surge in Covid-19 cases, the Center Initially stopped export of the drug to cater to local demand. Besides, in a meeting with manufacturers last week, the center also decided to facilitate fast track approval to companies to ramp up production capacities to make around 78 lakh vials per month, double the currently installed capacity of 38.80 lakh vials.
The government also negotiated with the manufacturers on pricing as they agreed to voluntarily reduce the price to ensure the medicine is adequately available and accessible to people during the pandemic.
However, some public health advocates raised concerns about a wide gap in MRP of different brands and urged the government to cap the prices using provisions for emergency situation. Cadila Healthcare, Cipla, Dr. Reddy’s Laboratories, Hetero Labs, Jubilant Pharma, Mylan and Syngene International are the local manufacturers of the medicine.
Cadila Healthcare’s Remdac is the cheapest drug at Rs 899 per vial.
Used for treating Ebola, the anti-viral drug remdesivir is an ‘investigation drug’ that has shown efficacy in the treatment of Covid-19 patients. However, the government has stressed that it is an ‘investigational drug’ and should be used only in hospital setting for Covid-19 patients on oxygen support. Health officials have strongly prohibited the use of the drug by patients at home.

.

Source link

Leave a Reply

Top
error: Content is protected !!